';
CLOSE
Authors Posts by Cathy Barrick

Cathy Barrick

693 POSTS 0 COMMENTS

0 1442
Photo by Tai's Captures on Unsplash

The Office of Developmental Programs (ODP) has shared ODPANN 025-110. This communication announces the availability of the Center for Disease Control (CDC) data website for Flu, Respiratory Syncytial Virus (RSV), and COVID-19, as well as provide updated information about respiratory illness prevention strategies, including available vaccinations.

The CDC reports that influenza hospitalizations are increasing nationally, RSV hospitalizations are increasing in the Southeastern and Southern states, and COVID-19 hospitalizations are low. Weekly respiratory illness severity updates, hospitalization rates, and other related data trends can be found on the CDC’s website.

Please review the announcement for more details.

0 518

Communication Bulletin 00-25-05 was published and shared last week. The purpose of the bulletin was to establish the Office of Developmental Programs’ (ODP’s) policy on communication and assure all individuals have an effective way to communicate.

To further provide access to the bulletin, ODP has shared another version of the bulletin in easier-to-understand terms and with pictures. This version will be available on MyODP as an attachment to the original bulletin communication released on December 1, 2025.

The following bulletins below are no longer in use:

  • Office of Developmental Programs 00-14-04, Accessibility of Intellectual Disability Services for Individuals Who Are Deaf
  • Office of Developmental Programs 00-08-18, Communication Supports and Services

0 933

The Office of Developmental Programs (ODP) has shared ODPANN 025-109 to provide clarification about the completion of the MA 51 or medical evaluation discussed in previous bulletin 00-25-02, along with a revised attachment.

Attachment:

The purpose of this requirement is to ensure that individuals are accessing healthcare at least once every three years. In practice, this will primarily affect those who are not receiving residential services, since residential licensing regulations already require annual physicals.

Please review the announcement for details.

0 346

The Office of Developmental Programs (ODP) has shared ODPANN 25-108, which gives information on a toolkit that is designed to assist providers with assessing and preparing for unexpected events to ensure the individuals they are supporting remain safe and continue to receive the services they need in the event of an emergency.

The Prepared People Save Lives Toolkit is available for download and use on the MyODP website.

It contains a Hazard Vulnerability Assessment (HVA), which will:

  • Identify and rank different hazards (natural disasters, technology failures, human-caused dangers);
  • Look at how vulnerable the program is and figure out what may need improvement through planning factors; and
  • Allow for continuous process improvement annually, making services resilient, and more prepared for emergencies.

Please review the communication for more details.

0 646

The Office of Developmental Programs (ODP) has shared ODPANN 25-107. This communication is to inform all interested parties that the Centers for Medicare and Medicaid Services (CMS) approved amendments to the 1915(b)(4) Performance-Based Contracting (PBC) waiver and the Consolidated, Community Living, and P/FDS Waivers effective January 1, 2026. All waivers are available on the Department of Human Services’ (DHS) website.

ODP will be holding one webinar to provide a high-level overview of Performance-Based Contracting and additional major changes made in the approved waivers. There will be time during the session for presenters to answer questions submitted by participants during the webinar.

Consolidated, Community Living, and P/FDS Waiver Amendment Overview
December 15, 2025
11:00 am – 12:00 pm
Register Here

Please review the ODP Announcement for more details.

0 598
Tablet on a desk - Newsletter

The Office of Developmental Programs (ODP) has shared ODPANN 25-085. This communication announces the release of a new issue of the quarterly newsletter, The Certified Investigator (CI) Program Spotlight. The CI Program Spotlight, Volume 2, Issue 3, may be found by logging into MyODP and visiting the CI Program Spotlight Newsletter web page.

0 5815

The Office of Developmental Programs (ODP) has shared this important announcement from the U. S. Food and Drug Administration (FDA).

The FDA is aware that Abbott Diabetes Care has sent all affected customers, distributors, and health care providers a letter regarding an issue with certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors providing incorrect low glucose readings. If undetected, incorrect low glucose readings over an extended period may lead to wrong treatment decisions for people living with diabetes, such as excessive carbohydrate intake or skipping or delaying insulin doses. These decisions may pose serious health risks, including potential injury or death, or other less serious complications.

As of November 14, 2025, Abbott has reported 736 serious injuries and seven deaths associated with this issue.

Affected Product

  • FreeStyle Libre 3 Sensor
    • Model Numbers: 72081-01, 72080-01
    • Unique Device Identifiers (UDI-DI): 00357599818005, 00357599819002
  • FreeStyle Libre 3 Plus Sensor
    • Model Numbers: 78768-01, 78769-01
    • Unique Device Identifiers (UDI-DI): 00357599844011, 00357599843014
  • Download the full list of affected lots

What to Do:

Patients should verify if their sensors are impacted and immediately discontinue use and dispose of the affected sensor(s).

On November 24, 2025, Abbott Diabetes Care sent all affected customers a letter recommending the following actions:

  • For Patients:
    • Determine if your current or unused sensor(s) are affected by visiting FreeStyle Check and selecting “CONFIRM SENSOR SERIAL NUMBER.” You will need to locate your sensor serial number to determine if your sensor is affected.
      • If you are wearing a FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensor, you can find the serial number in the app or reader. The serial number can also be found on the label on the bottom of the sensor applicator or carton. (If you are using a sensor with a connected insulin delivery device, please refer to the connected insulin delivery device user manual on how to locate the sensor serial number.)
    • If you are currently wearing or have a FreeStyle Libre 3 or FreeStyle Libre 3 Plus sensor that has been confirmed as potentially affected on FreeStyle Check or by a customer service representative, immediately discontinue use and dispose of the affected sensor(s).
    • You can request a replacement for any potentially affected sensor(s) on FreeStyle Check. Select “CONFIRM SENSOR SERIAL NUMBER” and enter a valid serial number. If your sensor is potentially impacted, you will be instructed to enter your contact information so a replacement product can be sent to you at no cost.
    • Use a blood glucose meter or the built-in meter in your FreeStyle Libre 3 Reader to make treatment decisions when your sensor readings don’t match your symptoms or expectations.

Visit the FDA’s website for additional information and instructions on how to locate the Sensor’s Serial Number.

Prev1...678...70Next Page 7 of 70
© 2021 - Rehabilitation & Community Providers Association